NCT07315230Not yet recruiting
Pediatric Midline Post Fossa Tumors Prognostic Factors and Outcomes
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
This study will follow children younger than 18 years with midline posterior fossa brain tumors who undergo standard surgical resection at Assiut University Hospital. The aim is to evaluate functional outcome using the modified Rankin Scale and to explore how tumor type, extent of resection, and perioperative factors are associated with postoperative morbidity and survival. Results may help improve risk stratification and guide individualized treatment strategies for pediatric patients with these tumors.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 18 Dec 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Assiut University
- Diseases
- Childhood cancers
- NCT number
- NCT07315230
What you commit to
- Study type: Observational
- Planned participants: 30
- From 1 Jan 2026 to the primary completion date, 31 Jan 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patient is unfit for surgery .
Other illness
- Secondary Malignancy: Metastatic disease.
Age
- patinent older than 18 years old
Other
- patients with non-midline posterior fossa or other brain tumors.
- Incomplete Data: Missing essential study data.
Who the study is looking for
- patients less than 18 years old
- patient with midline posterior fossa tumors
- patient is fit for surgery
Age in the registry: 0 years to 17 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.